Brief: GlycoMimetics Appoints Edwin Rock, M.D., Ph.D. As Chief Medical Officer
06/09/2022 12:45
Sept 6 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS APPOINTS EDWIN ROCK, M.D., PH.D. AS CHIEF
MEDICAL
OFFICER
Source text for Eikon: ID:nBw5lkJPGa
Further company coverage: GLYC.O
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering